Preclinical study of CD19 detection methods post tafasitamab treatment

INTRODUCTION: Several CD19 targeted antibody-based therapeutics are currently available for patients with diffuse large B-cell lymphoma (DLBCL), including the Fc-modified antibody immunotherapy tafasitamab. This therapeutic landscape warrants the evaluation of potential sequencing approaches. Prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilieva, Kristina, Eberl, Markus, Jaehrling, Jan, Blair, Derek, Patra-Kneuer, Maria, Boxhammer, Rainer, Alvarez Arias, Diana, Heitmüller, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622958/
https://www.ncbi.nlm.nih.gov/pubmed/37928552
http://dx.doi.org/10.3389/fimmu.2023.1274556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622958/
https://www.ncbi.nlm.nih.gov/pubmed/37928552
http://dx.doi.org/10.3389/fimmu.2023.1274556

Ejemplares similares